Brain Changes and Impact: The Neuropsychology of Parkinson's - Part 1

Sign up for updates on webinars, events, and resources for the Parkinson’s community—delivered to your inbox. https://dpf.org/newsletter-signup

In the first episode of our three-part series about neuropsychology and Parkinson’s, Connie Carpenter Phinney and Dr. Mark Mapstone explore how brain chemistry, especially dopamine, relates to thinking, movement, and mood in Parkinson’s. They break down key terms like cognition and executive function and offer insights into how Parkinson’s affects brain systems beyond motor symptoms.

This episode lays the groundwork for understanding how the brain works—and what happens when it changes.

This content is possible thanks to the generosity of our listeners. Every day more people are diagnosed with Parkinson’s, and this means our work is more important than ever. Please support our work by visiting https://dpf.org/donate. *

Interested in our Living with Parkinson's Meetup, Care Partner Meetup, or Live Well Today Webinars? Learn how to join. https://dpf.org/webinars

Visit https://dpf.org to learn more about the Davis Phinney Foundation for Parkinson's.

Speaker Bios:
Connie Carpenter Phinney
Connie Carpenter Phinney is a co-founder of the Davis Phinney Foundation and has been her husband’s care partner for over 25 years. Her background in science combined with her lived experience and curiosity helped shape this conversation with neuropsychologist Dr. Mark Mapstone. Connie is the host of the Foundation’s Care Partner Meetup, a monthly virtual meetup for Parkinson’s care partners held the first Tuesday of each month. To attend the meetup, sign up here: https://davisphinneyfoundation.org/ev...

Dr. Mark Mapstone

Mark Mapstone is Professor of Neurology at the University of California, Irvine School of Medicine. He is a member of the UCI Institute for Memory Impairments and Neurological Disorders and a Fellow of the UCI Center for Neurobiology of Learning and Memory. His research focuses on pre-clinical detection of neurological disease using cognitive tests and biomarkers obtained from blood. He has a special interest in developing strategies to maintain successful cognitive aging. In the clinic, he specializes in cognitive assessment of older adults with suspected brain disease. Dr. Mapstone earned a PhD in Clinical Psychology at Northwestern University and completed fellowship training in Neuropsychology and Experimental Therapeutics at the University of Rochester. He received a Career Development Award from the National Institute on Aging and his research has been funded by the National Institutes of Health, the Michael J. Fox Foundation, and the Department of Defense.